Banque Pictet & Cie SA
+9.81%
3か月リターン
$35.960
-0.601 (-1.67%)終値時点
Medline Inc. is a provider of medical-surgical products and supply chain solutions serving all points of care. The Company delivers mission-critical products used daily across the full range of care settings, from hospitals and surgery centers to physician offices and post-acute facilities. It operates through two segments: Medline Brand and Supply Chain Solutions. These segments offer approximately 335,000 medical-surgical products, including surgical and procedural kits, gloves and protective apparel, urological and incontinence care, wound care, and consumable lab and diagnostics products. Its Medline Brand products are organized into three product categories: Front Line Care, Surgical Solutions, and Laboratory and Diagnostics. The Supply Chain Solutions segment procures and distributes a variety of third-party products from national brands and also provides tailored logistics and supply chain optimization services to domestic and international consumers.
Medline Inc. is currently a hold. The stock is priced at $35.96, which is below the average analyst price target of $46, indicating potential upside. However, the forward P/E ratio is high at 20.92, suggesting that the stock may be overvalued at this price. Additionally, the recent drop in stock price by over 16% after lowering EBITDA guidance poses a risk, as it reflects market concerns about future profitability.

Medline Plans New Distribution Center in Michigan to Enhance Supply Chain Resilience

BFA Law Investigates Medline Inc. for Securities Fraud

Medline Launches Enhanced TrackPoint™ Inventory Management Solution

Medline Under Investigation for Possible Securities Violations

BFA Law Investigates Medline Inc. for Securities Fraud
Medline Inc. is a provider of medical-surgical products and supply chain solutions serving all points of care. The Company delivers mission-critical products used daily across the full range of care settings, from hospitals and surgery centers to physician offices and post-acute facilities. It operates through two segments: Medline Brand and Supply Chain Solutions. These segments offer approximately 335,000 medical-surgical products, including surgical and procedural kits, gloves and protective apparel, urological and incontinence care, wound care, and consumable lab and diagnostics products. Its Medline Brand products are organized into three product categories: Front Line Care, Surgical Solutions, and Laboratory and Diagnostics. The Supply Chain Solutions segment procures and distributes a variety of third-party products from national brands and also provides tailored logistics and supply chain optimization services to domestic and international consumers. It operates in the Healthcare sector.
Medline Inc. is currently a hold. The stock is priced at $35.96, which is below the average analyst price target of $46, indicating potential upside. However, the forward P/E ratio is high at 20.92, suggesting that the stock may be overvalued at this price. Additionally, the recent drop in stock price by over 16% after lowering EBITDA guidance poses a risk, as it reflects market concerns about future profitability.
投稿はまだありません
登録またはログインして議論に参加本ページは調査目的であり、投資助言ではありません。モデルは誤ることがあります。過去の実績は将来の成果を保証しません。